GGrantIndex
← Leaderboards

Min Shi

University Of Washington

$12,323,899
Attributed
$12,323,899
Total exposure
10
Grants
10
Lead (contact PI)

Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).

Funding over time

peak $4.6M · FY201424
$5M$3.8M$2.5M$1.3M$0
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24

Funding mix

By agency

NIH$12,323,899 · 10

By mechanism

R01$6,621,711 · 3
RF1$2,981,849 · 1
R21$1,513,375 · 4
R33$675,634 · 1
U01$531,330 · 1

Top collaborators

No co-investigators on record.

Most similar at University Of Washington

Same institution · by research overlap

Others in their field

Top investigators on “Alzheimer&Apos

Research focus

Alzheimer&AposS DiseaseProteinsPlasmaParkinson DiseaseDisease ProgressionSamplingBloodBiological MarkersPilot ProjectsCerebrospinal FluidAlpha SynucleinNeural Cell Adhesion Molecule L1Pharmaceutical PreparationsMonitorAffectCellsBody FluidsSeverity Of IllnessSocietiesNeurodegenerative DisordersExosomeBaseMicrovesicles

Grant awards (20)

Extracellular vesicle transport of brain-derived proteins to the blood in Alzheimer disease$703,563
R01 · FY2024 · AG · contact PI
Development of blood assays for multiple system atrophy and Parkinson disease$427,625
R21 · FY2024 · AG · contact PI
MicroRNAs in CNS-derived extracellular microvesicles as peripheral blood biomarkers for Alzheimer disease$675,268
R01 · FY2023 · AG · contact PI
Characterization and quantification of CNS cell specific extracellular microvesicles in blood$675,634
R33 · FY2022 · MH · contact PI
MicroRNAs in CNS-derived extracellular microvesicles as peripheral blood biomarkers for Alzheimer disease$675,269
R01 · FY2022 · AG · contact PI
Peptide Biomarkers for Alzheimer Disease$703,753
R01 · FY2021 · AG · contact PI
MicroRNAs in CNS-derived extracellular microvesicles as peripheral blood biomarkers for Alzheimer disease$675,268
R01 · FY2021 · AG · contact PI
Extracellular vesicle transport of brain-derived proteins to the blood in Alzheimer disease$2,981,849
RF1 · FY2020 · AG · contact PI
Peptide Biomarkers for Alzheimer Disease$703,699
R01 · FY2020 · AG · contact PI
MicroRNAs in CNS-derived extracellular microvesicles as peripheral blood biomarkers for Alzheimer disease$675,268
R01 · FY2020 · AG · contact PI
Targeted drug delivery via CNS cell specific exosomes in neurodegenerative diseases$194,375
R21 · FY2020 · AG · contact PI
Peptide Biomarkers for Parkinson Disease$1
U01 · FY2020 · NS · contact PI
Peptide Biomarkers for Alzheimer Disease$745,622
R01 · FY2019 · AG · contact PI
MicroRNAs in CNS-derived extracellular microvesicles as peripheral blood biomarkers for Alzheimer disease$675,268
R01 · FY2019 · AG · contact PI
Peptide Biomarkers for Parkinson Disease$531,329
U01 · FY2019 · NS · contact PI
Comparing Peptide Biomarkers for Alzheimer's Disease in Asians and non-Asians in the US$388,733
R01 · FY2019 · AG · contact PI
Exploring microvesicular transport across the blood-brain barrier as a novel a-synuclein clearance mechanism and source of Parkinson's disease biomarkers$233,250
R21 · FY2019 · NS · contact PI
Targeted drug delivery via CNS cell specific exosomes in neurodegenerative diseases$233,250
R21 · FY2019 · AG · contact PI
MicroRNAs in human body fluids as Parkinson disease biomarkers$193,125
R21 · FY2015 · NS · contact PI
MicroRNAs in human body fluids as Parkinson disease biomarkers$231,750
R21 · FY2014 · NS · contact PI